This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs
Owkin builds best-in-class predictive biomedical AI models and robust data sets
The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
Cryo-technology helps in early diagnosis and palliative care in later stages of cancer
State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem
The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis
Theradaptive's regenerative implants are best-in-class and are designed to permit precise tissue regeneration for a variety of tissue types and clinical indications
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
Subscribe To Our Newsletter & Stay Updated
